Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?.
Curr Vasc Pharmacol. 15(1), 47-50.
(2017). Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?.
J Hypertens. 33(11), 2185-97.
(2015). The effect of SGLT2 inhibitors on cardiovascular events and renal function..
Expert Rev Clin Pharmacol. 10(11), 1251-1261.
(2017). Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function..
JAMA Intern Med. 176(3), 409.
(2016). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017). Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 104-113.
(2018). Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?.
J Clin Hypertens (Greenwich). 18(8), 828.
(2016). Current challenges in antihypertensive treatment in the elderly..
Pol Arch Med Wewn. 126(7-8), 540-51.
(2016). Liraglutide and Renal Outcomes in Type 2 Diabetes..
N Engl J Med. 377(22), 2196.
(2017). Depression in hypertensive patients: the role of comorbidities..
J Hypertens. 34(7), 1441.
(2016). Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes..
N Engl J Med. 377(25), 2502.
(2017). Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?.
J Neurol Neurosurg Psychiatry. 88(3), 249-253.
(2017). Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
(2018). Pathogenesis and management of pruritus in cholestatic liver disease..
J Gastroenterol Hepatol. 27(7), 1150-8.
(2012). High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis..
Aliment Pharmacol Ther. 34(10), 1185-92.
(2011). Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma..
Clin Gastroenterol Hepatol. 10(2), 182-5.
(2012). Relationship between pedographic analysis and the Manchester scale in hallux valgus..
Acta Orthop Traumatol Turc. 49(1), 75-9.
(2015). A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer..
Cancer Immunol Immunother. 59(12), 1781-9.
(2010). Anatomic single-bundle anterior cruciate ligament reconstruction improves walking economy: hamstrings tendon versus patellar tendon grafts..
Knee Surg Sports Traumatol Arthrosc. 25(10), 3155-3162.
(2017). Anterior cruciate ligament deficiency reduces walking economy in "copers" and "non-copers"..
Knee Surg Sports Traumatol Arthrosc.
(2015). Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways..
J Matern Fetal Neonatal Med. 26(17), 1696-704.
(2013). Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy..
J Thyroid Res. 2015, 819072.
(2015). Hemispheric laterality assessment with dichotic digits testing in dyslexia and auditory processing disorder..
Int J Audiol. 49(3), 247-52.
(2010). CAPD Is Classified in ICD-10 as H93.25 and Hearing Evaluation-Not Screening-Should Be Implemented in Children With Verified Communication and/or Listening Deficits..
Am J Audiol. 25(4), 368-370.
(2016). Response to the Letter from Dr. Vermiglio Regarding Iliadou and Eleftheriadis (2017): CAPD is Classified in ICD-10 as H93.25..
J Am Acad Audiol. 29(3), 264-265.
(2018).